Ranbaxy Laboratories Limited: At the Crossroads

As India edged nearer to full membership of the World Trade Organisation in 2005, Indian pharmaceutical companies faced new realities. For Ranbaxy Laboratories, a major player in the Indian generic drugs market, a successful adaptation to life in this new market was key to the company’s future. This case, Ranbaxy Laboratories Limited: At the Crossroads by Amitava Chattopadhyay and Swati Srivastava examines one company facing choices in one of the fastest growing sectors of the Indian economy.

Like this content? Why not share it?
Share on FacebookTweet about this on TwitterGoogle+Share on LinkedInBuffer this pagePin on PinterestShare on Redditshare on TumblrShare on StumbleUpon

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.